Nautilus Biotechnology Inc Earnings: Beat on EPS

Nautilus Biotechnology Inc (NAUT) reported earnings per share of -$0.12 for the quarter ended March 31, 2026, beating analyst estimates of -$0.15 by $0.03. The biotech company delivered an 18.86% positive surprise on earnings expectations.

The actual loss of $0.12 per share represents a narrower loss than the consensus estimate, indicating improved operational performance relative to Wall Street projections. The 18.86% earnings surprise reflects the company’s ability to control costs more effectively than anticipated by analysts covering the stock.

NAUT’s quarterly results demonstrate progress in managing expenses as the company continues its biotechnology development initiatives. The $0.03 beat on EPS estimates suggests better-than-expected operational efficiency during the reporting period.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.